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Abstract
Objective. Recent advances in molecular techniques have revealed that there is bi-directional transfer of
cells between mother and child during pregnancy, and the presence of a mother’s cells in her child has
been termed maternal microchimerism (MMc). There is the potential for maternal cells to provoke inappro-
priate immune responses in the child, which could be a factor in autoimmunity including JDM. The aim
of this study was to determine whether maternal (female) cells could be detected in frozen muscle sec-
tions from seven males (age range 313 years) with JDM participating in the Juvenile Dermatomyositis
National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies
and sections of muscle controls (age range 212 years).
Methods. At least 1000 cells from each section underwent FISH and confocal imaging through each
nucleus. Concomitant IF for CD45 was used to determine whether MMc in muscle were lymphocytes.
A non-parametric MannWhitney U-test was used to detect statistical differences.
Results. The frequency of MMc was higher in JDM muscle (0.421.14%) than in controls (0.080.42%)
P=0.01. No CD45
+ MMc were observed.
Conclusion. These data confirm an increased frequency of MMc in JDM. More detailed characterization
of MMc is required, particularly using phenotypic markers, to explain the role of these cells in JDM.
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Introduction
It is now well established that cells cross the fetomater-
nal interface in both directions with relative efficiency; ma-
ternal cells engraft in fetal tissue and vice versa [1, 2].
Persistence of the mother’s cells in her offspring is
termed maternal microchimerism (MMc), whereas persist-
ence of fetal cells in the mother is termed fetal microchi-
merism (FMc). Both microchimeric states have persisted
for decades [3, 4], but it is unclear what role these cells
might have in health and disease. From an immunological
perspective, it is intriguing that the engrafting fetal or ma-
ternal cells are tolerated despite sharing only 50% genetic
identity with the surrounding cells. There are some clinical
observations to suggest that these cells may play a role
in susceptibility to autoimmune disease [5, 6], supporting
the theories that (i) the initial trigger in autoimmunity
may be alloimmune rather than autoimmune [7] or (ii) auto-
immunity is associated with a breakdown in tolerance to
microchimerism.
Some autoimmune diseases such as JDM and sclero-
derma share features with chronic graft vs host disease
(cGvHD), a complication of bone marrow transplantation.
Susceptibility to cGvHD is associated with incompatibility
between the HLA genes expressed by the invading popu-
lation from the donor and those of the recipient [8]. Given
that most autoimmune diseases like JDM occur in sub-
groups of the population carrying certain HLA genes, it
is reasonable to argue that HLA-incompatible alleles
from the invading microchimeric population may cause
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Ea similar reaction in these genetically susceptible individ-
uals. Indeed, there are now increasingly robust data sup-
porting a role for microchimerism in JDM [911].
JDM is a multisystem autoimmune disease that results
from inflammation of the small vessels of the muscle, skin,
gastrointestinal tract and other organs. The incidence of
JDM has been reported to be between 2 and 3/1000000
per year in children under 16 years of age [12], with an
excess in females. Although significant progress has been
made in the treatment of children with JDM, particularly
using steroids, secondary effects can result in growth
delay and osteopenia [13]. The underlying disease mech-
anisms are still poorly understood, but better understand-
ing of the aetiology of the disease could lead to more
targeted therapeutic strategies than broad-spectrum
steroids. Involvement of the immune system in JDM has
been demonstrated by the presence of lymphocytic and
phagocytic infiltrates in muscle biopsies from children
with JDM [14] and association with the HLA Class II
allele DQA1*0501 [15]. Studies over the last decade inves-
tigated MMc in JDM: maternally derived chimeric
cells were shown to be present more often in muscle
biopsies from children with JDM compared with controls
[9, 10]. Analysis of whole-blood DNA by quantitative
polymerase chain reaction demonstrated increased
MMc in children with JDM compared with their healthy
siblings [10, 11, 16]. Further, in unrelated healthy off-
spring, the presence of chimerism was shown to be asso-
ciated with HLA genotype of the mother, in particular HLA
DQA1*0501 [16]. In the same study, experiments on per-
ipheral blood lymphocytes showed that maternally
derived microchimeric cells are activated when exposed
to the JDM child’s lymphocytes, indicating that MMc is
immunologically active and may play a direct role in the
disease process [16]. The aim of this project was to use
state-of-the-art confocal imaging to determine whether
MMc could be detected in muscle biopsies from children
participating in the Juvenile Dermatomyositis Cohort




A total of 220 children with JDM were recruited prospect-
ively while 87 diagnosed children were recruited retro-
spectively to the JDCBS. Recruitment and structure of
the study were as described [17]. As well as detailed clin-
ical data, DNA, peripheral blood lymphocytes and muscle
biopsies are stored for analysis. As JDM predominantly
affects females, muscle biopsy sections were available
from seven males with JDM to allow identification of ma-
ternal cells using X chromosome-specific FISH.
Control tissue samples
Four control muscle sections were obtained: one from
Professor Seth Love, Pathologist North Bristol Trust,
from a 12-year-old boy with normal muscle pathology.
The remaining three control sections were obtained from
the JDCBS control cohort [18]. All three had been re-
ported as normal by two independent expert pathologists.
None of the four controls had any known muscle disease.
Ethical approval
Full written consent according to the Declaration of
Helsinki was obtained for all samples (MREC/1/3/22)
and appropriate local ethical approval was obtained
for all tissues (National Research Ethics Service
04/Q2002/35).
Strategy
Our approach was first to stain the X and Y chromo-
some using FISH and then to carry out concomitant IF
to identify the antigen(s) of interest. MMc cells were
identified, quantified and characterized using confocal
microscopy.
FISH with concomitant IF
Fresh frozen tissue sections of 7mm (stored at  80 C)
were fixed in acetone and air dried prior to a dehydration
series. The FISH probes (Vysis CEP X Spectrum Orange/Y
SpectrumGreen Direct Labelled Fluorescent DNA Probe,
Abbott Molecular Inc., Des Plaines, IL, USA) were pre-
pared according to the manufacturer’s recommendation,
and then applied on the tissue sections. DNA was dena-
tured at 73 C for 10min and then renatured with FISH
probes by incubating overnight at 42 C. The following
day, after post-hybridization washes, IF was started.
Non-specific binding was blocked by incubating the
slides with normal blocking serum for 60min. Subse-
quently, slides were incubated with primary antibody
(CD45-Mouse monoclonal; Dako UK Ltd, Ely, UK) for 4h
at 37 C, washed with 1  PBS/0.05% Tween-20, and then
incubated with fluorescent secondary antibodies for 2h at
37 C. For negative control slides, primary antibody was
replaced by normal blocking serum. Sequential staining
was performed for labelling double antigens. The sections
were then dehydrated through an ethanol series, air dried
and mounted with 40,6-diamidino-2-phenylindole (DAPI)
counterstain and mounting medium (Vector Laboratories,
Inc., Burlingame, CA, USA).
Analysis
All sections were analysed under a Leica SP5-AOBS con-
focal laser scanning microscope attached to a Leica DM
I6000 inverted epifluorescence microscope. Images were
taken by using a 63  magnification (oil) lens and 2  digital
zoom. Cells were analysed by assigning them to one of
four categories: X, Y, XY or XX. Video images are avail-
able. The FISH success rate (frequency of nuclei with both
the X and Y chromosome observable) was determined in
each sample. A MannWhitney non-parametric U-test
was used to determine statistical differences in MMC fre-
quency between the JDM and control groups.
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MMc identification in JDM and control tissue
MMc were identified by three colour fluorescence con-
focal imaging through individual nuclei as shown in
Fig. 1. More than 1000 cells were counted in each
sample. The results obtained are shown in Table 1.
Analysis of MMc frequency in JDM and control tissue
MMc were identified in all tissues undergoing detailed
examination (Fig. 2). More than 1000 cells underwent
analysis in each sample. The results obtained are shown
in Table 1. Comparison of data between cases and
controls showed a significant difference in MMc level
(P=0.01).
CD45 phenotyping
In order to establish whether maternal cells were of
lymphoid origin, CD45 immunoflourescence with con-
comitant FISH was carried out on JDM sample 6 and con-
trol sample 2. As expected, CD45
+ cells were observed




Our analysis identified female (presumed maternal) cells
in frozen muscle sections from seven males with well-
characterized JDM using FISH. The frequency of MMc
was higher in seven JDM muscle sections (0.421.14%)
than in muscle sections from four controls (0.080.42%)
(P=0.01). These data, generated using state-of-the-art
confocal imaging, validate and expand previous observa-
tions of increased frequency of MMc in male JDM tissue
[9, 10]. This increase in frequency suggests a role for MMc
in the pathogenetic mechanisms underlying JDM, yet
proof of this role has been elusive. One theory suggests
that these cells may be effector cells of the immune re-
sponse, whereas another proposes that a frequency of
MMc in tissue above a certain threshold could trigger an
immune reaction.
To determine whether MMc in JDM muscle was
lymphocytic in origin, the sections were co-stained with
an antibody to CD45 that recognizes the human CD45
TABLE 1 Subject characteristics, FISH success rate and MMc frequency in individuals with maternal microchimerism
and controls












JDM 1 13 years 4 months 13 years 5 months 1242 84 10 0.81
JDM 2 9 years 11 months 10 years 1 months 1052 78 12 1.14
JDM 3 4 years 7 months 4 years 9 months 1113 84 9 0.81
JDM 4 5 years 8 months 6 years 3 months 2362 87 10 0.42
JDM 5 3 years 11 months 4 years 1518 80 16 1.05
JDM 6 2 years 10 months 3 years 11 months 1128 76 10 0.89
JDM 7 4 years 2 months 4 years 3 months 1357 87 12 0.88
Control 1 NA 12 years 2618 80 2 0.08
Control 2 NA 5 years 8 months 1781 79 4 0.22
Control 3 NA 5 years 7 months 1420 74 5 0.42
Control 4 NA 2 years 5 months 1287 72 5 0.39
NA: not applicable.
FIG.1Confocal imaging through a maternal cell (highlighted by arrow). The X chromosome is indicated by a red dot and
the Y chromosome by a green dot. The nucleus is stained blue with DAPI. Imaging through this maternal cell, 2 X
chromosomes (and no Y chromosomes) are observed.
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Microchimerism in juvenile dermatomyositisantigen, a tyrosine phosphatase also known as the leuco-
cyte common antigen (LCA). CD45 is present in all human
cells of haematopoietic origin, except erythroid cells,
platelets and their precursor cells. While CD45
+ host
cells were identified and MMc was identified, no MMc
co-stained positive for CD45. This supports recent data
from Reed et al. [19] who did not identify CD45
+ maternal
cells. Further detailed characterization of maternal cells
in JDM tissue is required to clarify the role of MMc
in JDM. Work by the authors on the role of MMc in
type 1 diabetes suggests that MMc in type 1 diabetes
pancreas cells are tissue-specific insulin-producing b
cells [20, 21] rather than cells of the immune system.
Stevens et al. [22] showed that maternal cells constituted
0.0171.9% of parenchymal cells and were found in liver,
pancreas, lung, kidney, bladder, skin and spleen from
seven male infant studies in detail. It is therefore possible
that MMc plays different roles in different autoimmune
diseases.
A strength of this study is the well-characterized JDM
patient population from whom muscle biopsies were gen-
erally obtained shortly after diagnosis, but a weakness
is that FISH is only useful to detect maternal cells in
male biopsies with JDM. Improved strategies to detect
MMc in female tissue are an important area for future de-
velopment. The JDCBS represents a unique resource in
that multiple tissue samples are available from each par-
ticipant. It will therefore be possible to detect MMc
levels in different tissues from the same individuals.
One possibility is quantitative measurement of the non-
inherited maternal antigen in peripheral blood samples
that will require HLA genotyping of maternal DNA sam-
ples. This is likely to provide unique insights into the role
of MMc in JDM.
FIG.3Maternal cells identified in JDM biopsies do not express CD45. FISH staining as in Fig. 1. CD45
+ lymphocytes
(stained with FITCgreen) were observed in JDM tissue, but no CD45
+ MMc were observed.
FIG.2Female (presumed maternal) cells identified in male JDM tissue from three JDM cases. The X chromosome
is shown by a red dot, the Y chromosome by a green dot and the nucleus with DAPI (blue).
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of MMc in JDM, in particular, phenotyping muscle micro-
chimeric cells using a wide range of immunological,
muscle and muscle stem cell markers to determine
whether MMc in JDM are immune system or muscle
derived. Another future aim is to use state-of-the-art
laser capture technology to isolate and genotype these
maternal cells and adjacent host cells to prove that the
female cells in male tissue are maternal.
Rheumatology key messages
. Female (presumed maternal) cells can be identified
in JDM muscle and healthy muscle.
. Levels of maternal cells in JDM muscle are higher
than controls.
. Maternal cells in JDM tissue are not positive for the
lymphocytic marker CD45.
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